Zacks: Analysts Anticipate Agilent Technologies Inc (A) Will Announce Earnings of $0.73 Per Share
Equities research analysts predict that Agilent Technologies Inc (NYSE:A) will report earnings per share of $0.73 for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Agilent Technologies’ earnings, with the highest EPS estimate coming in at $0.75 and the lowest estimate coming in at $0.73. Agilent Technologies posted earnings per share of $0.67 in the same quarter last year, which suggests a positive year over year growth rate of 9%. The company is expected to announce its next quarterly earnings report on Monday, November 19th.
According to Zacks, analysts expect that Agilent Technologies will report full-year earnings of $2.71 per share for the current fiscal year, with EPS estimates ranging from $2.71 to $2.72. For the next year, analysts expect that the company will report earnings of $2.98 per share, with EPS estimates ranging from $2.92 to $3.04. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that follow Agilent Technologies.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Tuesday, August 14th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.04. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The company had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter in the prior year, the firm posted $0.59 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.0% on a year-over-year basis.
NYSE A opened at $64.66 on Friday. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.32 and a quick ratio of 2.88. Agilent Technologies has a 1 year low of $60.28 and a 1 year high of $75.00. The firm has a market capitalization of $21.20 billion, a price-to-earnings ratio of 27.40, a P/E/G ratio of 2.31 and a beta of 1.29.
In other news, Director Boon Hwee Koh sold 6,931 shares of the stock in a transaction dated Tuesday, June 12th. The shares were sold at an average price of $66.38, for a total transaction of $460,079.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
A number of hedge funds and other institutional investors have recently bought and sold shares of A. MRJ Capital Inc. raised its holdings in Agilent Technologies by 75.7% during the first quarter. MRJ Capital Inc. now owns 51,534 shares of the medical research company’s stock worth $3,447,000 after purchasing an additional 22,200 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Agilent Technologies by 21.2% during the first quarter. Wells Fargo & Company MN now owns 2,800,486 shares of the medical research company’s stock worth $187,353,000 after purchasing an additional 489,288 shares in the last quarter. Dupont Capital Management Corp raised its holdings in Agilent Technologies by 55.9% during the first quarter. Dupont Capital Management Corp now owns 8,533 shares of the medical research company’s stock worth $571,000 after purchasing an additional 3,060 shares in the last quarter. Dean Capital Investments Management LLC raised its holdings in Agilent Technologies by 121.0% during the first quarter. Dean Capital Investments Management LLC now owns 25,408 shares of the medical research company’s stock worth $1,700,000 after purchasing an additional 13,912 shares in the last quarter. Finally, Westpac Banking Corp raised its holdings in Agilent Technologies by 15.6% during the first quarter. Westpac Banking Corp now owns 22,782 shares of the medical research company’s stock worth $1,524,000 after purchasing an additional 3,068 shares in the last quarter.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Read More: Stock Symbol
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.